Skip to main content
. 2018 Feb 2;39(4):1591–1600. doi: 10.3892/or.2018.6245

Figure 5.

Figure 5.

Downregulation of miR-34a-5p predicts a poor prognosis in PC patients. (A) The expression level of miR-34a-5p was analyzed using qRT-PCR assay in PC tissues and their corresponding adjacent samples (n=139, ***P<0.001). (B) miR-34a-5p expression was measured by qRT-PCR assay in different tumor-node-metastasis (TNM) stages (*P<0.05, **P<0.01, ***P<0.001). (C) Patients with low miR-34a-5p expression had a worse prognosis than the patients with high miR-34a-5p expression (P<0.01). (D) miR-34a-5p expression was measured by qRT-PCR assay in 67 patients with PC in pre-operation and post-operation (P<0.001). PC, pancreatic cancer.